Tandem Diabetes Care, Inc.
TNDM
$22.72
-$0.41-1.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 2.97% | -14.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.97% | -14.86% | |||
| Cost of Revenue | -0.59% | -10.16% | |||
| Gross Profit | 5.84% | -18.32% | |||
| SG&A Expenses | 3.19% | -4.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.40% | -6.18% | |||
| Operating Income | 20.89% | -310.20% | |||
| Income Before Tax | -3.93% | -524.54% | |||
| Income Tax Expenses | -1.16% | -90.21% | |||
| Earnings from Continuing Operations | -3.80% | -3,362.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.80% | -3,362.31% | |||
| EBIT | 20.89% | -310.20% | |||
| EBITDA | 27.90% | -201.10% | |||
| EPS Basic | -2.85% | -3,327.59% | |||
| Normalized Basic EPS | -3.03% | -522.33% | |||
| EPS Diluted | -2.85% | -3,327.59% | |||
| Normalized Diluted EPS | -3.03% | -522.33% | |||
| Average Basic Shares Outstanding | 0.90% | 0.56% | |||
| Average Diluted Shares Outstanding | 0.90% | 0.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||